{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:54:40Z","timestamp":1781628880210,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Natural Science Foundation of Shandong Province, China","award":["ZR2024QH270"],"award-info":[{"award-number":["ZR2024QH270"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Encephalitis associated with antibodies against the \u03b1-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic acid receptor (AMPAR) is an extremely rare type of antibody-mediated encephalitis. Its clinical phenotype and neuroradiological characteristics remain incompletely described.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We present four cases of anti-AMPAR encephalitis, and a comprehensive literature review highlighted the diverse clinical experiences, with specific attention to the clinical and radiographic characteristics of anti-AMPAR encephalitis, as well as the association between clinical, neuroradiological presentations and outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 89 patients with anti-AMPAR encephalitis were included in this review. Clinical presentations at the onset of anti-AMPAR encephalitis were diverse, including behavioral, cognitive, motor, and sensory manifestations. Neuroradiological findings cannot be restricted to the limbic system. They may spread to unexpected sites, like basal ganglia, cerebellum, cerebral cortex regions, and even diffuse hyperintensities, or patient may have completely normal brain magnetic resonance imaging (MRI). Fisher\u2019s exact test showed that there was non-significant difference in the clinical symptoms and outcomes among different MRI presentations.Logistic regression analysis showed no significant correlations between clinical, neuroradiological findings and unfavorable outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Anti-AMPAR encephalitis mainly presents as limbic encephalitis, and most of the patients had positive brain MRI results. The range of hyperintensity on MRI may not be directly associated with patients\u2019 clinical symptoms and outcomes. For the expanding clinical profile of encephalitis associated with antibodies against AMPAR, careful databasing of new cases will facilitate more definitive study in the future.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-025-04608-4","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T05:40:38Z","timestamp":1767418838000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and neuroradiological findings in patients with Anti-AMPAR encephalitis: associations with outcomes"],"prefix":"10.1186","volume":"26","author":[{"given":"Shu","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,2]]},"reference":[{"key":"4608_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103118","volume":"21","author":"N Seery","year":"2022","unstructured":"Seery N, Butzkueven H, O\u2019Brien TJ, Monif M. Rare antibody-mediated and seronegative autoimmune encephalitis: an update. Autoimmun Rev. 2022;21:103118. https:\/\/doi.org\/10.1016\/j.autrev.2022.103118.","journal-title":"Autoimmun Rev"},{"issue":"9","key":"4608_CR2","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1708712","volume":"378","author":"J Dalmau","year":"2018","unstructured":"Dalmau J, Graus F. Antibody-mediated encephalitis. N Engl J Med. 2018;378(9):840\u201351. https:\/\/doi.org\/10.1056\/NEJMra1708712.","journal-title":"N Engl J Med"},{"issue":"4","key":"4608_CR3","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/ana.21589","volume":"65","author":"M Lai","year":"2009","unstructured":"Lai M, Hughes EG, Peng X, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol. 2009;65(4):424\u201334. https:\/\/doi.org\/10.1002\/ana.21589.","journal-title":"Ann Neurol"},{"issue":"3","key":"4608_CR4","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/ana.24293","volume":"77","author":"X Peng","year":"2015","unstructured":"Peng X, Hughes EG, Moscato EH, Parsons TD, Dalmau J, Balice-Gordon RJ. Cellular plasticity induced by anti-AMPA receptor encephalitis antibodies. Ann Neurol. 2015;77(3):381\u201398. https:\/\/doi.org\/10.1002\/ana.24293.","journal-title":"Ann Neurol"},{"key":"4608_CR5","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s00415-018-9153-8","volume":"266","author":"O Laurido-Soto","year":"2019","unstructured":"Laurido-Soto O, Brier MR, Simon LE, McCullough A, Bucelli RC, Day GS. Patient characteristics and outcome associations in AMPA receptor encephalitis. J Neurol. 2019;266:450\u201360. https:\/\/doi.org\/10.1007\/s00415-018-9153-8.","journal-title":"J Neurol"},{"key":"4608_CR6","doi-asserted-by":"publisher","unstructured":"Xuyi Wang C, Zhao Q, Chen et al. Anti-\u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor 2 encephalitis with olfactory hallucination: a case report and literature review. Front Immunol 2025;Feb 20:161444053. https:\/\/doi.org\/10.3389\/fimmu.2025.1444053","DOI":"10.3389\/fimmu.2025.1444053"},{"key":"4608_CR7","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/acn3.43","volume":"1","author":"AJ Gleichman","year":"2014","unstructured":"Gleichman AJ, Panzer JA, Baumann BH, Dalmau J, Lynch DR. Antigenic and mechanistic characterization of anti-AMPA receptor encephalitis. Ann Clin Transl Neurol. 2014;1:180\u20139. https:\/\/doi.org\/10.1002\/acn3.43.","journal-title":"Ann Clin Transl Neurol"},{"key":"4608_CR8","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1212\/WNL.0b013e3181cb3e52","volume":"74","author":"L Bataller","year":"2010","unstructured":"Bataller L, Galiano R, Garcia-Escrig M, et al. Reversible paraneoplastic limbic encephalitis associated with antibodies to the AMPA receptor. Neurology. 2010;74:265\u20137. https:\/\/doi.org\/10.1212\/WNL.0b013e3181cb3e52.","journal-title":"Neurology"},{"key":"4608_CR9","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1212\/WNL.0b013e3181d3e404","volume":"74","author":"F Graus","year":"2010","unstructured":"Graus F, Boronat A, Xifro X, et al. <article-title update=\"added\">The EXPANDING CLINICAL PROFILE OF ANTI-AMPA RECEPTOR ENCEPHALITIS. Neurology. 2010;74:857\u20139. https:\/\/doi.org\/10.1212\/WNL.0b013e3181d3e404.","journal-title":"Neurology"},{"key":"4608_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jneuroim.2013.05.011","volume":"261","author":"YC Wei","year":"2013","unstructured":"Wei YC, Liu CH, Lin JJ, et al. Rapid progression and brain atrophy in anti-AMPA receptor encephalitis. J Neuroimmunol. 2013;261:129\u201333. https:\/\/doi.org\/10.1016\/j.jneuroim.2013.05.011.","journal-title":"J Neuroimmunol"},{"key":"4608_CR11","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1001\/jamaneurol.2015.1715","volume":"72","author":"B Joubert","year":"2015","unstructured":"Joubert B, Kerschen P, Zekeridou A, et al. Clinical spectrum of encephalitis associated with antibodies against the alpha-amino-3-hydroxy-5-methyl \u2013\u20094-isoxazolepropionic acid receptor: case series and review of the literature. JAMA Neurol. 2015;72:1163\u20139. https:\/\/doi.org\/10.1001\/jamaneurol.2015.1715.","journal-title":"JAMA Neurol"},{"key":"4608_CR12","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1212\/WNL.0000000000001682","volume":"84","author":"R Hoftberger","year":"2015","unstructured":"Hoftberger R, van Sonderen A, Leypoldt F, et al. Encephalitis and AMPA receptor antibodies: novel findings in a case series of 22 patients. Neurology. 2015;84:2403\u201312. https:\/\/doi.org\/10.1212\/WNL.0000000000001682.","journal-title":"Neurology"},{"issue":"9","key":"4608_CR13","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1007\/s10072-023-06769-x","volume":"44","author":"J Lin","year":"2023","unstructured":"Lin J, Wang J, Li J. Patient characteristics and outcome in patients with anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) encephalitis. Neurol Sci. Sep; 2023;44(9):3253\u20139. https:\/\/doi.org\/10.1007\/s10072-023-06769-x.","journal-title":"Neurol Sci"},{"issue":"4","key":"4608_CR14","doi-asserted-by":"publisher","first-page":"e118","DOI":"10.1212\/NXI.0000000000000118","volume":"2","author":"R Marwa Elamin","year":"2015","unstructured":"Marwa Elamin R, Lonergan, Ronan P, Killeen. Sean O\u2019Riordan, Niall Tubridy, Christopher McGuigan. Posterior cortical and white matter changes on MRI in anti-AMPA receptor antibody encephalitis. Neurol Neuroimmunol Neuroinflamm. 2015;2(4):e118. https:\/\/doi.org\/10.1212\/NXI.0000000000000118.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"2","key":"4608_CR15","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.neuroimage.2012.01.021","volume":"62","author":"B Fischl","year":"2012","unstructured":"Fischl B. FreeSurfer. Neuroimage. 2012;62(2):774\u201381. https:\/\/doi.org\/10.1016\/j.neuroimage.2012.01.021.","journal-title":"Neuroimage"},{"key":"4608_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-225745","author":"N Samad","year":"2018","unstructured":"Samad N, Wong J. Anti-AMPA receptor encephalitis associated with medullary thyroid cancer. BMJ Case Rep. 2018. https:\/\/doi.org\/10.1136\/bcr-2018-225745. Aug 27:2018: bcr2018225745.","journal-title":"BMJ Case Rep"},{"key":"4608_CR17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s11940-017-0474-1","volume":"19","author":"S Mahajan","year":"2017","unstructured":"Mahajan S, Appleby BS. Comprehensive and methodical: diagnostic and management approaches to rapidly progressive dementia. Curr Treat Options Neurol. 2017;19:40. https:\/\/doi.org\/10.1007\/s11940-017-0474-1.","journal-title":"Curr Treat Options Neurol"},{"key":"4608_CR18","doi-asserted-by":"publisher","first-page":"e2546","DOI":"10.1212\/WNL.0000000000011937","volume":"96","author":"GS Day","year":"2021","unstructured":"Day GS, Yarbrough MY, Kortvelyessy P, et al. Prospective quantifcation of CSF biomarkers in antibody-mediated encephalitis. Neurology. 2021;96:e2546\u201357. https:\/\/doi.org\/10.1212\/WNL.0000000000011937.","journal-title":"Neurology"},{"issue":"1","key":"4608_CR19","doi-asserted-by":"publisher","first-page":"149","DOI":"10.4103\/0028-3886.310087","volume":"69","author":"VR Ashok","year":"2021","unstructured":"Ashok VR, Nagabushana D, Yashwanth G, Mahadevan A, Netravathi M. A rare case of Wobbly, psychotic patient with frozen Eyes - Anti-AMPA receptor encephalitis. Neurol India. 2021;69(1):149\u201352. https:\/\/doi.org\/10.4103\/0028-3886.310087. Jan-Feb.","journal-title":"Neurol India"},{"key":"4608_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000515930","volume":"17","author":"AA Murashko","year":"2021","unstructured":"Murashko AA, Pavlov KA, Pavlova OV, Gurina OI, Shmukler A. Antibodies against N-Methyl D-aspartate receptor in psychotic disorders: a systematic review. Neuropsychobiology. 2021;17:1\u201318. https:\/\/doi.org\/10.1159\/000515930.","journal-title":"Neuropsychobiology"},{"key":"4608_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/MD.0000000000025694","volume":"100","author":"J Yang","year":"2021","unstructured":"Yang J, et al. Anti-\u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor encephalitis: A case report. Medicine(Baltimore). 2021;100:17. https:\/\/doi.org\/10.1097\/MD.0000000000025694.","journal-title":"Medicine(Baltimore)"},{"issue":"2","key":"4608_CR22","first-page":"85","volume":"39","author":"H Zhu","year":"2018","unstructured":"Zhu H, Hou YB, Gao JG, Zhao T, Zhou CK, Liu JY. Limbic encephalitis associated with antibodies against the \u03b1-Amino-3-Hydroxy-5-Methyl-4- isoxazolepropionic acid receptor: a case report. Neuro Endocrinol Lett. May; 2018;39(2):85\u20137. https:\/\/pubmed.ncbi.nlm.nih.gov\/30183201.","journal-title":"Neuro Endocrinol Lett"},{"issue":"7","key":"4608_CR23","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.2169\/internalmedicine.9682-17","volume":"57","author":"Tsubasa Omi","year":"2018","unstructured":"Omi Tsubasa, Kinoshita Makoto, Nishikawa Akira, Tomioka Takahito, Ohmori Kenichi, Fukada Kei, et al. Clinical relapse of anti-AMPAR encephalitis associated with recurrence of thymoma. Intern Med. 2018;57(7):1011\u20133. https:\/\/doi.org\/10.2169\/internalmedicine.9682-17.","journal-title":"Intern Med"},{"key":"4608_CR24","doi-asserted-by":"publisher","unstructured":"Onugoren M Dogan, Deuretzbacher D, Haensch CA, et al. Limbic encephalitis due to GABAB and AMPA receptor antibodies: a case series. J Neurol Neurosurg Psychiatry. 2014(9). https:\/\/doi.org\/10.1136\/jnnp-2014-308814.","DOI":"10.1136\/jnnp-2014-308814"},{"issue":"5","key":"4608_CR25","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200012","volume":"9","author":"Elizabeth Matthews","year":"2022","unstructured":"Matthews Elizabeth, Schmitt Barrie, Passeri Michlene, Mizenko Christopher, Orjuela Karen, Piquet Amanda. AMPA receptor encephalitis in a patient with metastatic breast cancer receiving palbociclib: a case report. Neurol Neuroimmunol Neuroinflamm. 2022;9(5):e200012. https:\/\/doi.org\/10.1212\/NXI.0000000000200012.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"3","key":"4608_CR26","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1007\/s10072-024-07850-9","volume":"46","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Gao F, Wang WSZ, Zheng Y. Cortical ribbon sign in AMPAR antibody-associated encephalitis mimicking Creutzfeldt-Jakob disease. Neurol Sci. 2025;46(3):1443\u20136. https:\/\/doi.org\/10.1007\/s10072-024-07850-9.","journal-title":"Neurol Sci"},{"issue":"4","key":"4608_CR27","doi-asserted-by":"publisher","first-page":"e118","DOI":"10.1212\/NXI.0000000000000118","volume":"2","author":"M Elamin","year":"2015","unstructured":"Elamin M, Lonergan R, Killeen RP, O Riordan S, Tubridy N, McGuigan C. Posterior cortical and white matter changes on MRI in anti-AMPA receptor antibody encephalitis. Neurol Neuroimmunol Neuroinfamm. 2015;2(4):e118. https:\/\/doi.org\/10.1212\/NXI.0000000000000118.","journal-title":"Neurol Neuroimmunol Neuroinfamm"},{"key":"4608_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/273192","volume":"2015","author":"Giuseppe Quaranta","year":"2015","unstructured":"Quaranta Giuseppe, Maremmani Angelo Giovanni Icro, Perugi Giulio. Anti-AMPA-receptor encephalitis presenting as a rapid-cycling bipolar disorder in a young woman with Turner syndrome. Case Rep Psychiatry. 2015;273192. https:\/\/doi.org\/10.1155\/2015\/273192.","journal-title":"Case Rep Psychiatry"},{"issue":"1","key":"4608_CR29","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1186\/s12883-021-02520-1","volume":"16","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Fan S, Ren H, Zhou L, Guan H. Clinical characteristics and prognosis of anti-alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic acid receptor encephalitis. BMC Neurol. Dec 2021;16(1):490. https:\/\/doi.org\/10.1186\/s12883-021-02520-1.","journal-title":"BMC Neurol"},{"key":"4608_CR30","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/nrn2867","volume":"11","author":"GL Collingridge","year":"2010","unstructured":"Collingridge GL, Peineau S, Howland JG, Wang YT. Long-term depression in the CNS. Nat Rev Neurosci. 2010;11:459\u201373. https:\/\/doi.org\/10.1038\/nrn2867.","journal-title":"Nat Rev Neurosci"},{"key":"4608_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.827138","volume":"13","author":"Yuanyuan Luo","year":"2022","unstructured":"Luo Yuanyuan, et al. Autoimmune encephalitis with psychotic manifestations and cognitive impairment presenting as schizophrenia: case report and literature review. Front Psychiatry. 2022;13:827138. https:\/\/doi.org\/10.3389\/fpsyt.2022.827138.","journal-title":"Front Psychiatry"},{"key":"4608_CR32","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","volume":"12","author":"MJ Titulaer","year":"2013","unstructured":"Titulaer MJ, McCracken L, Gabilondo I, Armangu\u00e9 T, Glaser C, Iizuka T, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12:157\u201365. https:\/\/doi.org\/10.1016\/S1474-4422(12)70310-1.","journal-title":"Lancet Neurol"},{"key":"4608_CR33","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jaut.2018.10.014","volume":"96","author":"J Broadley","year":"2019","unstructured":"Broadley J, Seneviratne U, Beech P, Buzzard K, Butzkueven H. Prognosticating autoimmune encephalitis: a systematic review. J Autoimmun. 2019;96:24\u201334. https:\/\/doi.org\/10.1016\/j.jaut.2018.10.014.","journal-title":"J Autoimmun"},{"issue":"3","key":"4608_CR34","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1159\/000515592","volume":"84","author":"M Yu Jia","year":"2021","unstructured":"Yu Jia M, Li H, Wang M, Zhang Y, Wang. The peculiar clinical symptoms and treatment of limbic encephalitis associated with AMPA receptor antibody. Eur Neurol. 2021;84(3):206\u201311. https:\/\/doi.org\/10.1159\/000515592.","journal-title":"Eur Neurol"},{"issue":"2","key":"4608_CR35","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1474-4422(13)70282-5","volume":"13","author":"N Gresa-Arribas","year":"2014","unstructured":"Gresa-Arribas N, Titulaer MJ, Torrents A, Aguilar E, McCracken L, Leypoldt F, et al. Antibody titres at diagnosis and during followup of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol. 2014;13(2):167\u201377. https:\/\/doi.org\/10.1016\/S1474-4422(13)70282-5.","journal-title":"Lancet Neurol"},{"issue":"11","key":"4608_CR36","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1007\/s10072-016-2680-0","volume":"37","author":"J Shuangshuang Yang","year":"2016","unstructured":"Shuangshuang Yang J, Qin J, Li Y, Gao L, Zhao J, Wu B, Song Y, Xu, Shilei Sun. Rapidly progressive neurological deterioration in anti-AMPA receptor encephalitis with additional CRMP5 antibodies. Neurol Sci. 2016;37(11):1853\u20135. https:\/\/doi.org\/10.1007\/s10072-016-2680-0.","journal-title":"Neurol Sci"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04608-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04608-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04608-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:01:28Z","timestamp":1781625688000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-025-04608-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,2]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4608"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04608-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7438732\/v1","asserted-by":"object"}]},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,2]]},"assertion":[{"value":"23 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were performed according to the Declaration of Helsinki and ethical approval was obtained from the Ethics Committee from The First Affiliated Hospital of Shandong First Medical University. All participants gave written informed consent. In the case of participants with cognitive decline, the legal guardian or an appropriate representative of these participants provided informed consent on their behalf.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patients gave written informed consent for their personal or clinical details along with any identifying images to be published in this study. In the case of participants with memory disorders, written informed consent for publication of clinical details and\/or clinical images was obtained from the family of the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"64"}}